Figure 6
Figure 6. Aberrant mural cell recruitment in human IPF lungs. (A) Immunohistochemistry of lymphatic vessels with the marker D2-40 on on-IPF lung tissue and IPF samples. Scale bars equal 200 μm. (B) Quantitative analysis of D2-40–positive vessels in lung tissue of IPF- and non-IPF patients (non-IPF n = 3, IPF n = 12). (C) Quantitative analysis of D2-40–positive lymphatic vessels associated with PDGFR-β–positive mural cells in lung tissue of IPF- and non-IPF–patients (non-IPF n = 3, IPF n = 12). (D) Simultaneous immunodetection of lymphatic vessels and pericytes, with the markers D2-40 and PDGFR-β, on non-IPF lung tissue and IPF samples. Scale bars equal 50 μm. Error bars show SEM.

Aberrant mural cell recruitment in human IPF lungs. (A) Immunohistochemistry of lymphatic vessels with the marker D2-40 on on-IPF lung tissue and IPF samples. Scale bars equal 200 μm. (B) Quantitative analysis of D2-40–positive vessels in lung tissue of IPF- and non-IPF patients (non-IPF n = 3, IPF n = 12). (C) Quantitative analysis of D2-40–positive lymphatic vessels associated with PDGFR-β–positive mural cells in lung tissue of IPF- and non-IPF–patients (non-IPF n = 3, IPF n = 12). (D) Simultaneous immunodetection of lymphatic vessels and pericytes, with the markers D2-40 and PDGFR-β, on non-IPF lung tissue and IPF samples. Scale bars equal 50 μm. Error bars show SEM.

Close Modal

or Create an Account

Close Modal
Close Modal